Exelixis in the NEWS

Exelixis CABOMETYX is approved for the treatment of many cancers. The product has been game changer in the treatment of various difficult to treat cancers before the products that target PD-L1 and approved for several various  cancers were developed by MRK and BMY.    

Exelixis (EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data . . .